Our Company History

1981
Foundation of Galderma as a joint venture between L’Oréal and Nestlé.
1984
Galderma discovers Adapalene.
1986
First commercial operations.
1995
Launch of Adapalene for acne treatment.
2000
Opening of our production site in Baie d’Urfé, Canada.
2001
Licensing agreement for Skin cancer treatment product.
2004
Opening of our production site in Hortolândia, Brazil.
2007
Launch of Adapalene 0.3%.
2008
Launch of Adapalene/Benzoyl Peroxide combination product.
2009
Launch of neuromodulator and Restylane Injector.
2009
Acquisition of Sculptra.
2011
Acquisition of Q-med, maker of Restylane.
2014
Nestlé Skin Health is founded – Galderma becomes a wholly-owned subsidiary of Nestlé.
2019
Galderma debuts as the world’s largest independent global dermatology company following acquisition by a consortium of institutional investors.
2021
Acquisition of Alastin Skincare.
2022
Divestment of Alchemee.
2022
Launch of Liquid neuromodulator.
2023
Launch of Sculptra in Thailand
1981
Foundation of Galderma as a joint venture between L’Oréal and Nestlé.
1984
Galderma discovers Adapalene.
1986
First commercial operations.
1995
Launch of Adapalene for acne treatment.
2000
Opening of our production site in Baie d’Urfé, Canada.
2001
Licensing agreement for Skin cancer treatment product.
2004
Opening of our production site in Hortolândia, Brazil.
2007
Launch of Adapalene 0.3%.
2008
Launch of Adapalene/Benzoyl Peroxide combination product.
2009
Launch of neuromodulator and Restylane Injector.
2009
Acquisition of Sculptra.
2011
Acquisition of Q-med, maker of Restylane.
2014
Nestlé Skin Health is founded – Galderma becomes a wholly-owned subsidiary of Nestlé.
2019
Galderma debuts as the world’s largest independent global dermatology company following acquisition by a consortium of institutional investors.
2021
Acquisition of Alastin Skincare.
2022
Divestment of Alchemee.
2022
Launch of Liquid neuromodulator.
2023
Launch of Sculptra in Thailand

Are you looking for a clinic?

Find your nearest Clinic